Data for (Study ST000699)

(Analysis AN001085)

Values for each metabolite have been scaled by dividing by the mean across all factors

Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

MetaboliteF1F2F3
CL 78:11; [M-2H](2-)@6.24 1.0987 0.8603 1.0131
CL 82:11; [M-2H](2-)@6.91 0.2508 0.5803 2.0850
PC 30:0; [M-Ac-H]-@5.94 1.0570 0.7803 1.1188
PC 32:0; [M-Ac-H]-@6.51 0.9180 0.9726 1.1039
PC 32:0; [M-Ac-H]-@6.59 0.9180 0.9726 1.1039
PC 34:1; [M-Ac-H]-@6.67 0.9843 1.0393 0.9843
PC 34:2; [M-Ac-H]-@6.23 0.8060 1.1114 1.1049
PC 36:0; [M-Ac-H]-@7.69 1.4183 0.7831 0.7552
PC 36:2; [M-Ac-H]-@6.82 0.7033 1.1791 1.1534
PC 36:3; [M-Ac-H]-@6.38 0.7348 1.3333 0.9985
PC 36:4; [M-Ac-H]-@6.13 0.9810 1.1531 0.8965
PC 38:2; [M-Ac-H]-@7.42 0.9330 1.0013 1.0659
PC 38:3; [M-Ac-H]-@7.05 0.9684 1.2235 0.8528
PC 38:4; [M-Ac-H]-@6.79 0.9138 1.2224 0.9083
PC 38:6; [M-Ac-H]-@6.06 0.8145 1.0209 1.1688
PC 40:5; [M-Ac-H]-@6.91 0.7517 1.3319 0.9828
PC 40:6; [M-Ac-H]-@6.71 0.8103 1.2296 1.0060
PE 32:1; [M-H]-@6.22 1.4612 0.3358 1.0702
PE 35:0; [M-H]-@7.54 1.1502 1.0064 0.8447
PE 36:0; [M-H]-@7.82 1.2733 0.8242 0.8674
PE 36:1; [M-H]-@7.40 1.0772 0.9709 0.9460
PE 37:4; [M-H]-@6.68 1.3913 0.7846 0.7810
PE 38:6; [M-H]-@6.18 1.1645 0.8774 0.9336
PE 40:6; [M-H]-@6.90 0.2436 0.4746 2.1767
PG 36:0; [M-H]-@6.97 1.3070 0.9703 0.7168
PI 38:4; [M-H]-@5.99 1.0490 1.1201 0.8549
plasmenyl-PE 36:4; [M-H]-@6.67 0.7136 1.2818 1.0609
plasmenyl-PE 38:3; [M-H]-@7.41 0.7484 0.9977 1.2534
plasmenyl-PE 38:5; [M-H]-@6.70 0.6801 1.2012 1.1589
plasmenyl-PE 38:6; [M-H]-@6.57 0.9511 0.7781 1.2265
Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

Factors:

F1Diagnosis:ERM
F2Diagnosis:PDR
F3Diagnosis:RD
  logo